FI981337A - Process for the preparation of virus-safe pharmaceutical compositions - Google Patents

Process for the preparation of virus-safe pharmaceutical compositions Download PDF

Info

Publication number
FI981337A
FI981337A FI981337A FI981337A FI981337A FI 981337 A FI981337 A FI 981337A FI 981337 A FI981337 A FI 981337A FI 981337 A FI981337 A FI 981337A FI 981337 A FI981337 A FI 981337A
Authority
FI
Finland
Prior art keywords
virus
preparation
pharmaceutical compositions
safe pharmaceutical
safe
Prior art date
Application number
FI981337A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI106465B (en
FI981337A0 (en
Inventor
Hannele Toeloe
Jaakko Parkkinen
Original Assignee
Suomen Punainen Risti Veripalv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suomen Punainen Risti Veripalv filed Critical Suomen Punainen Risti Veripalv
Priority to FI981337A priority Critical patent/FI106465B/en
Publication of FI981337A0 publication Critical patent/FI981337A0/en
Priority to AU47834/99A priority patent/AU4783499A/en
Priority to EP99931279A priority patent/EP1086120A1/en
Priority to PCT/FI1999/000505 priority patent/WO1999064441A1/en
Publication of FI981337A publication Critical patent/FI981337A/en
Application granted granted Critical
Publication of FI106465B publication Critical patent/FI106465B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Water Supply & Treatment (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI981337A 1998-06-10 1998-06-10 A process for preparing virus-safe pharmaceutical compositions FI106465B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FI981337A FI106465B (en) 1998-06-10 1998-06-10 A process for preparing virus-safe pharmaceutical compositions
AU47834/99A AU4783499A (en) 1998-06-10 1999-06-09 Method for preparing virus-safe pharmaceutical compositions
EP99931279A EP1086120A1 (en) 1998-06-10 1999-06-09 Method for preparing virus-safe pharmaceutical compositions
PCT/FI1999/000505 WO1999064441A1 (en) 1998-06-10 1999-06-09 Method for preparing virus-safe pharmaceutical compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI981337 1998-06-10
FI981337A FI106465B (en) 1998-06-10 1998-06-10 A process for preparing virus-safe pharmaceutical compositions

Publications (3)

Publication Number Publication Date
FI981337A0 FI981337A0 (en) 1998-06-10
FI981337A true FI981337A (en) 1999-12-11
FI106465B FI106465B (en) 2001-02-15

Family

ID=8551961

Family Applications (1)

Application Number Title Priority Date Filing Date
FI981337A FI106465B (en) 1998-06-10 1998-06-10 A process for preparing virus-safe pharmaceutical compositions

Country Status (4)

Country Link
EP (1) EP1086120A1 (en)
AU (1) AU4783499A (en)
FI (1) FI106465B (en)
WO (1) WO1999064441A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10211632A1 (en) * 2002-03-15 2003-10-09 Aventis Behring Gmbh Process for the separation of viruses from a protein solution by nanofiltration
ITMI20031940A1 (en) * 2003-10-09 2005-04-10 Prodotti Chimici Alimentari METHOD FOR FELLING THE INFECTIOUS AGENTS OF TSE IN BILE AND DERIVATIVES
CN1890257A (en) 2003-12-01 2007-01-03 诺和诺德医疗保健公司 Virus filtration of liquid factor vii compositions
WO2007017242A2 (en) * 2005-08-08 2007-02-15 Csl Behring Gmbh Novel virus reduction method based on detergents and shearing forces
WO2012090067A1 (en) 2010-12-30 2012-07-05 Lfb Biotechnologies Glycols as pathogen inactivating agents
AU2018284707B2 (en) 2017-06-12 2021-11-11 Asahi Kasei Medical Co., Ltd. Method for filtering protein-containing liquid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680175A (en) * 1984-02-07 1987-07-14 Interferon Sciences, Inc. Interferon administration vehicles
DE3603444A1 (en) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K PHARMACEUTICAL PREPARATIONS FOR STABILIZING INTERFERON ALPHA
DE4217335C2 (en) * 1992-05-26 1996-01-18 Seitz Filter Werke Hydrophilic membrane and process for its manufacture
EP1104809A1 (en) * 1994-04-09 2001-06-06 F. Hoffmann-La Roche Ag Process for producing alpha-interferon

Also Published As

Publication number Publication date
FI106465B (en) 2001-02-15
FI981337A0 (en) 1998-06-10
EP1086120A1 (en) 2001-03-28
AU4783499A (en) 1999-12-30
WO1999064441A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
FI20090217A (en) Process for the preparation of food compositions
DK1275387T3 (en) Process for the preparation of high-bioavailability phenofibrate pharmaceutical compositions
NO20010475D0 (en) Process for the preparation of antimicrobial articles
NO20006630L (en) Pharmaceutical composition for the treatment of diabetes
PT1066027E (en) PHARMACEUTICAL COMPOSITION OF TOPIRAMATO
HUP0201376A2 (en) Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
EE04450B1 (en) Pharmaceutical compositions for aerosols with two or more active ingredients
FI20010155A (en) Process for the preparation of citalopram
HUP0004120A3 (en) Use of cgmp-pde5 inhibitors for the preparation of pharmaceutical compositions treating neuropathy
PT1242087E (en) PHARMACEUTICAL COMPOSITIONS
ID18352A (en) PHARMACEUTICAL COMPOSITIONS
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
HUP0202191A3 (en) Substituted polycyclic aryl and heteroaryl pirazinones useful for selective inhibition of the coagulation cascade and pharmaceutical compositions containing them
IL146104A0 (en) Substituted bicyclic heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing the same
PT1239832E (en) PHARMACEUTICAL COMPOSITIONS
NO20005000D0 (en) Process for the preparation of glass-making ingredients
EE9900206A (en) Pharmaceutical compositions containing N-sulfonylindoline derivatives
FI981337A (en) Process for the preparation of virus-safe pharmaceutical compositions
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
PT941100E (en) PHARMACEUTICAL COMPOSITIONS
ITMI942166A0 (en) PHARMACEUTICAL COMPOSITIONS MIORELAXANTS
IS5569A (en) pharmaceutical compositions
HUP0003159A3 (en) The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions
HUP0001441A3 (en) Process for the preparation of pharmaceutical compositions containing 4-aza-androst-1-ene derivatives
NO20012811D0 (en) Process for the preparation of p-chlorophenyl-propanol derivative